Muhlenkamp Fund (MUHLX)

53.71
Net Asset Value
+0.02%
1 Day
-2.72%
Year-to-Date
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
1.27%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize total after-tax return to its shareholders through capital appreciation- and income from dividends and interest- consistent with reasonable risk. The fund principally invests in a diversified list of common stocks of companies of any capitalization- determined by the investment adviser to be highly profitable- yet undervalued. Muhlenkamp & Company- Inc. (the "Adviser") looks for companies the advisor believes to have above-average profitability- as measured by corporate return-on-equity- and that sell at below-average prices- as measured by price-to-earnings-ratios.

Performance

1 month+1.36% 3 years-0.17%
3 months+1.34% 5 years+4.32%
1 year+6.90% Since inception+8.76%
Data through --

Peer Comparisonvs. Large blend

 MUHLXCategory
Performance 5-yr return+4.32%+11.72%
Expense ratio1.27%0.95%
Risk 5 year sharpe ratio0.291.07
Net assets$231.7M$5.7B
Average market cap$36.0B$152.3B
Average P/E15.920.6
Portfolio turnover19%19%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMuhlenkamp
Fund manager & tenureRonald Muhlenkamp / 29 Years
Minimal initial investment$1,500.00
Minimum IRA investment--

Holdings

U.S. stock73.61%
International stock11.64%
Cash11.12%
Fixed income3.63%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 28.02%
Telecommunication 15.23%
Consumer goods 12.73%
Consumer service 9.80%
Financial service 7.96%
Top 10 Holdings
Portfolio weighting
ON ON Semiconductor Corp5.91%
GILD Gilead Sciences5.75%
MSFT Microsoft5.12%
AAPL Apple5.02%
ADS Alliance Data Systems Corp4.98%
RUSHA Rush Enterprises Inc4.46%
TCEHY Tencent4.42%
UNH UnitedHealth4.26%
BMY Bristol-Myers Squibb4.02%
GLD SPDR® Gold Shares3.63%